Advair Diskus Once Daily
Links shared publicly online about this topic
Therapeutics Daily
therapeuticsdaily.com — “Therapeutics Daily” View full resource at therapeuticsdaily.com
Most Recently Shared on August 25, 2009 at 5:39 pm By:
Glaxo: 2 Lots of Advair Diskus Stolen From Plant -- http://tinyurl.com/n5k5ou
Clinical Cases and Images: CasesBlog: Top 10 Most Prescribed Medications
casesblog.blogspot.com — “Health News Updated Daily by an Assistant Professor at University of Chicago, Internist and Allergist” View full resource at casesblog.blogspot.com
Most Recently Shared on May 19, 2011 at 12:48 pm By:
Advair Diskus #4, Singulair #6 as best selling drugs in US #drves- http://goo.gl/B3A5p
GSK lung drug has mixed results but filing on track - Yahoo! News
news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday. The new once-a-day inhaled medicine showed superiority to GSK's existing twice-daily drug Advair in one trial for chronic lung disease, but not another. That patchy record echoes results of other studies in an extensive development program. Britain's biggest drugmaker, howeve” View full resource at news.yahoo.com
Most Recently Shared on March 23, 2012 at 1:23 pm By:
GSK lung drug has mixed results but filing on track: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to sub... http://t.co/W4eIxzVS
GSK lung drug has mixed results but filing on track - Yahoo! News
news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing another batch of mixed clinical trial results on Friday. The new once-a-day inhaled medicine showed superiority to GSK's existing twice-daily drug Advair in one trial for chronic lung disease, but not another. That patchy record echoes results of other studies in an extensive development program. Britain's biggest drugmaker, howeve” View full resource at news.yahoo.com
Most Recently Shared on March 23, 2012 at 1:31 pm By:
GSK lung drug has mixed results but filing on track - LONDON (Reuters) - GlaxoSmithKline reiterated a plan to submit... http://t.co/pn6eaUBd
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
PharmaLive
-
Michael Blaiss, MD
Allergist. Past President of the American College of Allergy, Asthma, and Immunology
-
Lungs and Breathing
Organizing lung and breathing resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement

